Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06285136
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-29
First Post:
2024-02-18
Brief Title:
Safety and Efficacy of Venetoclax Combination With DecitabineDEC3-VEN in the Treatment of AML in the Adult
Sponsor:
The Second Affiliated Hospital of Kunming Medical University
Organization:
The Second Affiliated Hospital of Kunming Medical University
Study Overview
Official Title:
The Second Affiliated Hospital of Kunming Medical University
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study proposes to conduct a prospective multicenter single-arm study to explore the efficacy and safety of venetoclax in combination with high-dose decitabine DEC3-VEN in new diagnosed adult patients with AML and to provide evidence for the optimal selection of clinical treatment regimens which is planned to be conducted in 10 research centers across the country
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None